Smith & Nephew plc Common Stock

As of the most recent data (June 2026), SNN shows a common stock of $180M. That compares with $170M in the prior-year period — up 0.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SNN's common stock is now $180M (was $170M) — a 0.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Smith & Nephew plc is outperforming or lagging.

Tracking SNN's common stock over time shows whether Smith & Nephew plc is scaling, shrinking, or reshaping that part of the business. The current reading is $180M That compares with $170M in the prior-year period — up 0.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Smith & Nephew plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $180M) with ownership activity and broader fundamentals.

Smith & Nephew plc's common stock is $180M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.